MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Valemetostat in Combination With Atezolizumab in People With Lung Cancer
What the film says
This trial is for extensive stage small cell lung cancer, as maintenance therapy, in adults.
The idea: test valemetostat together with atezolizumab. The researchers will test different doses of valemetostat to find the highest dose that causes few or mild side effects. Then they test that dose in a new group of patients to learn more about safety. Daiichi Sankyo is listed as a collaborator.
This phase 1 study plans 24 patients. At Memorial Sloan Kettering Cancer Center in New York, Jessica Ross leads it.
Public record; not medical advice.
Sources behind this film
Extensive stage small cell lung cancer, as maintenance therapy, adults; Valemetostat together with atezolizumab; Different doses to find the highest dose with few or mild side effects; Then test that dose in a new group of patients to learn more about safety (+3 more lines)
The drug
Dose level -1 100 mg po once daily Dose level 1 150 mg po once daily Dose level 2 200 mg po once daily
The study
This study will test whether valemetostat in combination with atezolizumab is a safe treatment that causes few or mild side effects in people with extensive-stage small cell lung cancer (SCLC). The researchers will test different doses of valemetostat to find the highest dose that causes few or mild side effects in participants.
After the dose is found, researchers will test it in a new group of participants to learn more about the safety of the study treatment and see if it is an effective treatment for extensive-stage SCLC.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.